Table 3 Results of immunohistochemical staining in SDH-deficient renal cell carcinoma

From: Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma

Patient

Tumor

SDHB

SDHA

PAX8

Ksp-cad

S100A1

EMA

AE1/AE3

CAM 5.2

CK7

CD10

RCC

AMACR

Chromogranin

Synaptophysin

Cathepsin K

TFE3

HMB45

CAIX

KIT

Vimentin

HNF1B

1

1

Lost

Retained

100%

NA

10%

10%

80%

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Mast cells

Mast cells

Retained

1

2

Lost

Retained

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

NA

Mast cells

NA

2

3

Lost

Retained

100%

100%

5%

80%

80%

NA

5%

NA

NA

NA

NA

NA

Mast cells

40%

Retained

3

4

Lost

Retained

100%

90%

80%

60%

30%

90%

30%

Mast cells

Mast cells

Retained

4

5

Lost

Retained

100%

100%

5%

5%

NA

NA

NA

NA

NA

NA

Mast cells

Mast cells

Retained

5

6

Lost

Retained

90%

90%

80%

60%

10%

10%

60%

<5%

NA

Mast cells

NA

Retained

6

7

Lost

Retained

100%

100%

90%

50%

80%

NA

NA

Mast cells

NA

Retained

7

8

Lost

Retained

80%

100%

80%

75%

10%

NA

Mast cells

Mast cells

Retained

8

9

Lost

Lost

100%

NA

80%

30%

<5%

NA

Mast cells

NA

Retained

9

10

Lost

Retained

80%

100%

100%

25%

90%

50%

Mast cells

Mast cells

Retained

10

11

Lost

Retained

100%

100%

50%

60%

80%

NA

Mast cells

Mast cells

Retained

  1. Abbreviations: AMACR, alpha-methylacyl-coA-racemase; EMA, epithelial membrane antigen; Ksp-cad, kidney-specific cadherin; mast cells, highlights intratumoral mast cells but negative in tumor cells; NA, not available; RCC, renal cell carcinoma antigen; SDH, succinate dehydrogenase.